Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
6962 | 1347 | 27.7 | 74% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1085 | 9394 | RADICAL HYSTERECTOMY//CERVICAL CANCER//VULVAR CANCER |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | UTERINE NEOPLASMS MR | Author keyword | 11 | 52% | 1% | 15 |
2 | PET DIAG | Address | 10 | 73% | 1% | 8 |
3 | UTERINE NEOPLASMS STAGING | Author keyword | 6 | 45% | 1% | 10 |
4 | UTERINE NEOPLASMS DIAGNOSIS | Author keyword | 6 | 42% | 1% | 11 |
5 | OVARY NEOPLASMS | Author keyword | 5 | 23% | 1% | 18 |
6 | PERITONEUM NEOPLASMS | Author keyword | 4 | 75% | 0% | 3 |
7 | UTERINE NEOPLASMS | Author keyword | 4 | 12% | 2% | 30 |
8 | UTERINE NEOPLASMS MR STUDIES | Author keyword | 3 | 57% | 0% | 4 |
9 | MALLINCKRODT RADIOL NUCL MED | Address | 3 | 100% | 0% | 3 |
10 | OVARY RADIONUCLIDE STUDIES | Author keyword | 3 | 100% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | POST THERAPY SURVEILLANCE | 38 | 89% | 1% | 17 |
2 | LYMPH NODAL METASTASIS | 24 | 82% | 1% | 14 |
3 | PET CONTRAST ENHANCED CT | 23 | 74% | 1% | 17 |
4 | POSTTHERAPY SURVEILLANCE | 21 | 85% | 1% | 11 |
5 | ASYMPTOMATIC ADNEXAL MASSES | 16 | 64% | 1% | 16 |
6 | UTERINE CERVICAL CARCINOMA | 12 | 40% | 2% | 23 |
7 | PELVIC COMPUTED TOMOGRAPHY | 10 | 73% | 1% | 8 |
8 | PRETREATMENT EVALUATION | 10 | 58% | 1% | 11 |
9 | 2 FLUORINE 18 FLUORO 2 DEOXY D GLUCOSE | 9 | 37% | 1% | 19 |
10 | PARAMETRIAL INVASION | 8 | 75% | 0% | 6 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Evaluating PET-CT in the detection and management of recurrent cervical cancer: systematic reviews of diagnostic accuracy and subjective elicitation | 2014 | 5 | 27 | 78% |
CA 125, PET alone, PET-CT, CT and MRI in diagnosing recurrent ovarian carcinoma A systematic review and meta-analysis | 2009 | 67 | 54 | 57% |
Diagnostic performance of computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography/computer tomography for detection of metastatic lymph nodes in patients with cervical cancer: Meta-analysis | 2010 | 34 | 81 | 78% |
Radiological evaluation of lymph node metastases in patients with cervical cancer - A meta-analysis | 1997 | 182 | 56 | 50% |
Accuracy of 18-F-FDG PET imaging in the follow up of endometrial cancer patients: Systematic review and meta-analysis of the literature | 2013 | 9 | 26 | 54% |
Risk stratification and prognosis determination using F-18-FDG PET imaging in endometrial cancer patients: A systematic review and meta-analysis | 2014 | 4 | 30 | 50% |
The special role of ultrasound for screening, staging and surveillance of malignant ovarian tumors: distinction from other methods of diagnostic imaging | 2014 | 6 | 43 | 35% |
Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review | 2003 | 130 | 23 | 52% |
Clinical evidence on PET-CT for radiation therapy planning in cervix and endometrial cancers | 2010 | 20 | 38 | 68% |
Application of FDG-PET in Cervical Cancer and Endometrial Cancer: Utility and Future Prospects | 2014 | 2 | 42 | 62% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PET DIAG | 10 | 73% | 0.6% | 8 |
2 | MALLINCKRODT RADIOL NUCL MED | 3 | 100% | 0.2% | 3 |
3 | GYNECOL PELV SURG | 2 | 43% | 0.2% | 3 |
4 | BIOMED FDN NW LOUISIANA | 1 | 50% | 0.1% | 2 |
5 | MED RADIOTECHNOL | 1 | 30% | 0.2% | 3 |
6 | ALVIN J SITEMAN CANC MED | 1 | 50% | 0.1% | 1 |
7 | BEREICH BRUSTCHIRURG SENOL | 1 | 50% | 0.1% | 1 |
8 | BIOMR | 1 | 50% | 0.1% | 1 |
9 | BUPA IRELAND | 1 | 50% | 0.1% | 1 |
10 | CLIN PHYSIOL NUCL MED DIAGNOST INVEST | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000159221 | CERVICAL CANCER//CERVIX CANCER//LOCALLY ADVANCED CERVICAL CANCER |
2 | 0.0000144487 | RISK OF MALIGNANCY INDEX//ADNEXAL MASSES//ADNEXAL MASS |
3 | 0.0000105502 | INTERVAL DEBULKING SURGERY//SECONDARY CYTOREDUCTIVE SURGERY//ADVANCED OVARIAN CANCER |
4 | 0.0000104419 | LYMPHATIC SYSTEM MR//LYMPHOGRAPHY//INTERSTITIAL MR LYMPHOGRAPHY |
5 | 0.0000088361 | VIRTUAL CYSTOSCOPY//BLADDER NEOPLASMS STAGING//BLADDER NEOPLASMS CT |
6 | 0.0000087736 | RADICAL HYSTERECTOMY//RADICAL TRACHELECTOMY//TRACHELECTOMY |
7 | 0.0000070794 | INTRAVOXEL INCOHERENT MOTION//DIFFUSION WEIGHTED IMAGING//APPARENT DIFFUSION COEFFICIENT |
8 | 0.0000070040 | ATSUCHI MEM RADIOL//HAMAMATSU MED IMAGING//PET ANGIOGRAPHY |
9 | 0.0000067435 | ENDOMETRIAL CANCER//ENDOMETRIAL CARCINOMA//UTERINE PAPILLARY SEROUS CARCINOMA |
10 | 0.0000066195 | ADENOMYOSIS//ATYPICAL POLYPOID ADENOMYOMA//UTERINE PERISTALSIS |